facebook pixel

Category: BU Law in the Media

Carb-X Funds Microbion to Develop Inhaled Drug to Treat Cystic Fibrosis-Related Lung Infections

CARB-X announced today it is awarding Microbion Corporation of Bozeman, MT, USA, up to $6.1 million plus up to $5.4 million more if certain project milestones are met, to develop its anti-infective drug pravibismane for the treatment of cystic fibrosis (CF)-related pulmonary infections. The research project is CARB-X’s first award for the development of an […]

Tags: